Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome

被引：35
|
作者：
da Silva, Elizabeth Nicole [1 ,2 ]
Randall, Katrina Louise [1 ,2 ]
机构：
[1] Canberra Hosp, Dept Immunol, Canberra, ACT, Australia
[2] Australian Natl Univ, Sch Med, Canberra, ACT, Australia
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2013年 / 1卷 / 06期
关键词：
D O I：
10.1016/j.jaip.2013.07.004
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：687 / 688
页数：2
相关论文
共 50 条
  • [41] Honey bee venom re-challenge during specific immunotherapy: prolonged cardio-pulmonary resuscitation allowed survival in a case of near fatal anaphylaxis
    Micaletto, Sara
    Ruetzler, Kurt
    Bruesch, Martin
    Schmid-Grendelmeier, Peter
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2022, 18 (01):
  • [42] A Case of Neuropathic Pain in Monoclonal Mast Cell Activation Syndrome
    Bay, Jeannie L.
    Sedarsky, Kaye E.
    Petersen, Maureen M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB74 - AB74
  • [43] A case of neuropathic pain in monoclonal mast cell activation syndrome
    Bay, Jeannie L.
    Sedarsky, Kaye E.
    Petersen, Maureen M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 120 (05) : 543 - 544
  • [44] Omalizumab is effective as add-on treatment in a patient with systemic mastocytosis (SM) and recurrent anaphylaxis during venom immunotherapy (VIT)
    Jandus, P.
    Hausmann, O.
    Haeberli, G.
    Mueller, U.
    Helbling, A.
    ALLERGY, 2010, 65 : 567 - 567
  • [45] AN AUDIT OF INDUCTION HONEY BEE VENOM IMMUNOTHERAPY AT THE FIONA STANLEY HOSPITAL (ADULT AND PAEDIATRIC) AND OUR EXPERIENCE WITH THE SUBSEQUENT USE OF OMALIZUMAB AS AN ADJUNCTIVE THERAPY
    Williams, Terri
    Mallon, Dominic
    Tansy, Jody
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 23 - 24
  • [46] Successful treatment of idiopathic mast cell activation syndrome with low-dose Omalizumab
    Berry, Renee
    Hollingsworth, Peter
    Lucas, Michaela
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2019, 8 (10)
  • [47] Fatal anaphylaxis following a hornet sting in a yellow jacket venom-sensitized patient with undetected monoclonal mast cell activation syndrome and without previous history of a systemic sting reaction
    Blank, Simon
    Pehlivanli, Sinan
    Methe, Heiko
    Schmidt-Weber, Carsten B.
    Biedermann, Tilo
    Horny, Hans-Peter
    Kristensen, Thomas
    Amar, Yacine
    Koeberle, Martin
    Brockow, Knut
    Stoemmer, Peter E.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (01): : 401 - +
  • [48] Systemic T-cell unresponsiveness during rush bee-venom immunotherapy
    Segura, JA
    Assenmacher, M
    Irsch, J
    Hunzelmann, N
    Radbruch, A
    ALLERGY, 1998, 53 (03) : 233 - 240
  • [49] Mast cell-derived prostaglandin D2 limits the subcutaneous absorption of honey bee venom in mice
    Fujiwara, Yuki
    Nakamura, Tatsuro
    Maehara, Toko
    Hayashi, Akane
    Aritake, Kosuke
    Murata, Takahisa
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (22)
  • [50] Increased Excretion of Mast Cell Mediator Metabolites During Mast Cell Activation Syndrome
    Butterfield, Joseph H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (08): : 2542 - 2546
12345